NUS — Stock Film
STOCK FILMSCENE 1/11NUS · $5.27
Stock Expert AI presents
NUS
Nu Skin Enterprises, Inc
~4 min film100% real numbers0 jargon
WHAT DOES THIS COMPANY DO?
Nu Skin Enterprises, Inc. A quick introduction.

On the stock market since 1996, it operates in the everyday-essentials business. It has 2,800 employees. Now — the numbers.

on the stock market since 1996
2,800 employees
$255.9M market value
Revenue last year:
$0
The net profit left over:
$0
Out of every $100 in sales, $11 stays as net profit.
THE SLICE THAT TURNS INTO PROFIT: 11%

This is an established company with proven profits.

WHERE DOES THE MONEY COME FROM?
92%Manufacturing
Manufacturing 92%Rhyz Other 8%Nu Skin 1%
92% of all revenue comes from a single line: Manufacturing.

That much dependence is a risk in itself: if this one line weakens, the whole company feels it directly.

THE SALES TREND
Sales have been shrinking.

An average decline of 14% a year over the last 4 years — the most striking risk in this picture. Red columns mark years that ended in a loss.

$2.7B
2021
$2.2B
2022
$2B
2023
$1.7B
2024
$1.5B
2025
INSIDE THE REPORT CARD

We compared this company with its own sector across five subjects.

A score of 50 means class average.

BUSINESS QUALITY
79
strong

Clearly above the class average — a step short of the very top.

FINANCIAL STRENGTH
69
strong

A solid grade overall — yet the debt outweighs the cash. The strength here comes from earnings power.

VALUATION
99
very strong

The price looks reasonable next to what the company earns.

GROWTH
33
very weak

Clearly below the class average.

PRICE MOMENTUM
14
very weak

Clearly below the class average.

WORTH WATCHING

Price Momentum: The stock has lagged the market in recent months; investor interest is weak right now.

Growth: Sales growth trails the sector average.

THE COUNCIL REVIEW
9

angles, checked one by one.

The 4 that stand out are on screen; the rest came back neutral.

The council scores out of 10; report-card grades are out of 100.

STRENGTHS
Fat profit per sale, but shrinking10/10
Few are betting against it10/10
WEAK SPOTS
The stock has lost its spark0/10
Growth has stalled2/10
WORTH WATCHING

Revenue Growth: Sales are growing slowly.

THE FIVE-YEAR JOURNEY
A long and steep decline.

An investor who bought at the very peak is down 91% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.

1
THE BRIGHT SIDE · 1/3
Executives are buying their own stock

Over the last 12 months, company executives reported 20 buys and 18 sells. Management buying with its own money is usually read as a good sign.

2
THE BRIGHT SIDE · 2/3
Analysts’ target sits above today’s price

The average analyst price target is $11.00109% above today’s price.

3
THE BRIGHT SIDE · 3/3
Pays a steady dividend

It pays out $0.24 per share each year — regular cash for whoever holds the stock.

1
THE RISKS · 1/3
Sales are shrinking

Over the last 3 years, sales fell about 13% a year on average. Profit is holding up, but a shrinking business is a risk worth watching.

2
THE RISKS · 2/3
The stock has lost its spark

Buyers haven’t stepped back in yet; the price hasn’t found its footing. Report-card grade: 14/100. For a turnaround signal, the stock first needs to close the gap with the market.

3
THE RISKS · 3/3
Growth trails the sector

The growth engine is running at low revs right now. Report-card grade: 33/100.

FINALE · THE GRADE
B
0 / 100 · MoonshotScore

On our five-subject report card, NUS sits near the top of the class. A high grade doesn’t mean “guaranteed win” — it means “the evidence looks strong for now.”

The takeaway: NUS is an established business that has proven its profits for years. The real debate here isn’t the price — it’s whether the company can keep up this pace.

The total grade weighs these five subjects against the sector — it isn’t a simple average of the five.

What would you like to do next?
Open the stock page →
This was a film — not investment advice.
Data: FMP & company filings
Jul 21, 2026 · stockexpertai.com · Stock Film